---
title: "Mr David Freedman — Ownership Dossier"
canonical: https://whiteintel.dev/entity/51345e93-e079-4af1-8a43-ef8301d79d9f
json: https://whiteintel.dev/api/public/dossier/51345e93-e079-4af1-8a43-ef8301d79d9f
identifier: psc:1RU8PFLN1jAFjjHhznJ2wLxzKto
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Mr David Freedman

**Type:** Person  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:1RU8PFLN1jAFjjHhznJ2wLxzKto`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/51345e93-e079-4af1-8a43-ef8301d79d9f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/51345e93-e079-4af1-8a43-ef8301d79d9f  

## Ownership & control

### Holdings / subsidiaries

- **PHARMETHICALS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/c368114f-05a9-5e15-848b-629abe11665e

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Mr David Freedman**. Human view: https://whiteintel.dev/entity/51345e93-e079-4af1-8a43-ef8301d79d9f · Structured JSON: https://whiteintel.dev/api/public/dossier/51345e93-e079-4af1-8a43-ef8301d79d9f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._